4.7 Review

The complexity of the BAFF TNF-family members: Implications for autoimmunity

期刊

JOURNAL OF AUTOIMMUNITY
卷 39, 期 3, 页码 189-198

出版社

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jaut.2012.05.009

关键词

BAFF; APRIL; TWEAK; TWE-PRIL; Variants; SNPs; Autoimmune diseases

资金

  1. Fondation Arthritis-Courtin
  2. Fundacion Valle del Lili

向作者/读者索取更多资源

The B-cell activating factor belonging to the tumor-necrosis factor family BAFF contributes to autoimmune disorders. As such, BAFF might become a therapeutic target. However, this molecule has pleiotropic effects that are as numerous as they are varied. The real effect of each form (spliced, glycosylated, membrane bound, soluble, homotrimerized, heterotrimerized, multimerized) has not been well characterized yet. Consequently, conflicting results, regarding the serum concentrations of BAFF or its functional effect, exist in literature. BAFF quantification based on ELISA commercial kits was indeed found to be inaccurate. The complexity of the various forms of BAFF will be reviewed by focusing on the different structural aspects of the molecule. These data have particular implications for autoimmunity, not only because of the role of these factors on B cell growth and survival, but also their influence on the onset and severity of several autoimmune diseases. (C) 2012 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

The regulatory capacity of B cells directs the aggressiveness of CLL

Audrey Mohr, Marie Cumin, Cristina Bagacean, Pierre Pochard, Christelle Le Dantec, Sophie Hillion, Yves Renaudineau, Christian Berthou, Adrian Tempescul, Hussam Saad, Jacques-Olivier Pers, Anne Bordron, Christophe Jamin

ONCOIMMUNOLOGY (2019)

Article Rheumatology

Mortality in patients with systemic lupus erythematosus in Colombia: a case series

David Aguirre-Valencia, Ana Suarez-Avellaneda, Vanessa Ocampo-Piraquive, Ivan Posso-Osorio, Juan Naranjo-Escobar, Ivana Nieto-Aristizabal, Gabriel J. Tobon, Carlos A. Canas

CLINICAL RHEUMATOLOGY (2019)

Correction Rheumatology

Mortality in patients with systemic lupus erythematosus in Colombia: a case series (vol, pg, )

David Aguirre-Valencia, Ana Suarez-Avellaneda, Vanessa Ocampo-Piraquive, Ivan Posso-Osorio, Juan Naranjo-Escobar, Ivana Nieto-Aristizabal, Gabriel J. Tobon, Carlos A. Canas

CLINICAL RHEUMATOLOGY (2019)

Article Rheumatology

Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a single-center experience with 63 patients

I. Nieto-Aristizabal, T. Martinez, M-A Urbano, I. Posso-Osorio, I. F. Plata, J. E. Garcia-Robledo, C. C. Aragon, V. A. Santos, G. J. Tobon

Article Rheumatology

Reproducibility of minor salivary gland biopsy reports in Sjogren's syndrome and its correlation with disease biomarkers

Alvaro J. Vivas, Mario Bautista-Vargas, Sebastian Portacio, Andres Garces-Palacio, Maria-Alejandra Urbano, Andres Agualimpia, Ingrid Ruiz-Ordonez, Ivana Nieto-Aristizabal, Gabriel J. Tobon

Summary: This study showed good concordance between rheumatologists and pathologists in interpreting MSGB results for SS diagnosis. There was a strong association between interstitial plasmocytes and SS, indicating the potential predictive value of specific histological findings for the development of SS. MSGB is an essential tool for diagnosing SS despite factors that may impact its reproducibility.

CLINICAL RHEUMATOLOGY (2021)

Review Biochemistry & Molecular Biology

Hyposialylation Must Be Considered to Develop Future Therapies in Autoimmune Diseases

Anne Bordron, Marie Morel, Cristina Bagacean, Maryvonne Dueymes, Pierre Pochard, Anne Harduin-Lepers, Christophe Jamin, Jacques-Olivier Pers

Summary: Sialylation plays a crucial role in autoimmunity, with hyposialylation often leading to inflammation and organ damage. A better understanding of this mechanism will help improve treatment strategies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Immunology

Abatacept Promotes Regulatory B Cell Functions, Enhancing Their Ability to Reduce the Th1 Response in Rheumatoid Arthritis Patients through the Production of IL-10 and TGF-β

Guillermo Carvajal Alegria, Divi Cornec, Alain Saraux, Valerie Devauchelle-Pensec, Christophe Jamin, Sophie Hillion, Jacques-Olivier Pers, Pierre Pochard

Summary: The study showed that abatacept enhances the immunoregulatory properties of B cells by increasing their production of IL-10 and TGF-beta, leading to a suppression of T cell activation and differentiation, ultimately promoting the generation of regulatory T cells.

JOURNAL OF IMMUNOLOGY (2021)

Article Medical Laboratory Technology

Association of Antiribosomal P Antibody with Neurological and Systemic Manifestations in Patients with Systemic Lupus Erythematosus in Southwestern Colombia

Juan-David Marin, Sthephany Vargas, Ingrid Ruiz-Ordonez, Ivan Posso-Osorio, Ivana Nieto-Aristizabal, Maria Claudia Barrera, Lady J. Rios-Serna, Gabriel J. Tobon

Summary: This study examined the clinical significance and serological associations of serum antiribosomal P antibodies in SLE patients in southwestern Colombia. The results showed a significant association between anti-P antibodies and anti-Smith, anti-Ro60/SSA, and anti-dsDNA antibodies, but not with neuropsychiatric SLE, lupus nephritis, or hepatic involvement.

JOURNAL OF APPLIED LABORATORY MEDICINE (2022)

Article Rheumatology

Systemic erythematosus lupus and pregnancy outcomes in a Colombian cohort

Valeria Erazo-Martinez, Ivana Nieto-Aristizabal, Isabella Ojeda, Michelle Gonzalez, Cristian C. Aragon, Maria Andrea Zambrano, Gabriel J. Tobon, Johanna Arango, Alex Echeverri, David Aguirre-Valencia

Summary: Pregnant women with SLE have a higher risk of maternal complications, including preterm labor, preeclampsia, and preterm rupture of membranes. Disease activity and lupus nephritis in SLE may lead to adverse maternal outcomes.
Letter Rheumatology

Rheumatological diseases in patients with primary hyperparathyroidism

Valeria Erazo-Martinez, Jose Alejandro-Posso, Carolina Medellin, Michiko Kaimoto, Carlos A. Canas, Gabriel J. Tobon

RHEUMATOLOGY (2022)

Article Multidisciplinary Sciences

B-cell activating factor (BAFF) and its receptors' expression in pediatric nephrotic syndrome is associated with worse prognosis

Jessica Forero-Delgadillo, Vanessa Ochoa, Jaime M. Restrepo, Laura Torres-Canchala, Ivana Nieto-Aristizabal, Ingrid Ruiz-Ordonez, Aura Sanchez, Maria Claudia Barrera, Carlos Andres Jimenez, Gabriel J. Tobon

Summary: This study evaluates the expression of B-cell activating factor (BAFF) and its receptors in renal samples from pediatric nephrotic syndrome (NS) patients and finds a relationship between BAFF expression and renal function survival. BAFF expression in podocytes and interstitial inflammatory infiltrates (III) is associated with worse renal function outcomes, indicating that BAFF expression could be a prognostic factor for renal function.

PLOS ONE (2022)

Article Medicine, General & Internal

Increase in direct costs for health systems due to lupus nephritis: the case of Colombia

Sergio I. Prada, Ana M. Perez, Ivana Nieto-Aristizabal, Gabriel J. Tobon

Summary: This study aimed to describe the direct costs of lupus nephritis in Colombia, showing that patients with lupus nephritis incurred significantly higher costs compared to those without nephritis. The cost difference was mainly attributed to the cost and frequency of procedures in lupus nephritis patients.

EINSTEIN-SAO PAULO (2022)

Article Immunology

Lymphomagenesis predictors and related pathogenesis

Ingrid Ruiz-Ordonez, Juan-Manuel Piedrahita, Javier-Andres Arevalo, Andres Agualimpia, Gabriel J. Tobon

Summary: The study explores predictors associated with lymphomagenesis in Sjogren's syndrome patients through a comprehensive literature review, identifying new biomarkers and emphasizing the importance of recognizing markers for worse prognosis in the lymphoproliferation process.

JOURNAL OF TRANSLATIONAL AUTOIMMUNITY (2021)

Article Immunology

Therapeutic Plasma Exchange as a Treatment for Autoimmune Neurological Disease

Ivana Nieto-Aristizabal, Alvaro J. Vivas, Pablo Ruiz-Montano, Cristian C. Aragon, Ivan Posso-Osorio, Jairo Quinones, Julian Alejandro Rivillas, Gabriel J. Tobon

AUTOIMMUNE DISEASES (2020)

Article Immunology

Therapeutic Plasma Exchange as Management of Complicated Systemic Lupus Erythematosus and Other Autoimmune Diseases

David Aguirre-Valencia, Juan Naranjo-Escobar, Ivan Posso-Osorio, Maria Carmenza Macia-Mejia, Ivana Nieto-Aristizabal, Tatiana Barrera, Maria Alejandra Obando, Gabriel J. Tobon

AUTOIMMUNE DISEASES (2019)

Article Immunology

Isolation and characterisation of PR3-specific B cells and their immunoglobulin sequences

Shane Kelly, Katherine J. L. Jackson, Timothy J. Peters, Dan Suan, Christopher C. Goodnow

Summary: This study successfully identified and characterized PR3-specific B cells from the peripheral blood of patients with PR3 autoantibodies. These cells exhibited specific immunological features, suggesting that PR3 self-reactivity may occur early in B-cell development.

JOURNAL OF AUTOIMMUNITY (2024)

Article Immunology

Targeting NF-κB signaling in B cells as a potential new treatment modality for ANCA-associated vasculitis

Ana Merino-Vico, Jan Piet van Hamburg, Paul Tuijnenburg, Giulia Frazzei, Aram Al-Soudi, Carlo G. Bonasia, Boy Helder, Abraham Rutgers, Wayel H. Abdulahad, Coen A. Stegeman, Jan-Stephan Sanders, Laura Bergamaschi, Paul A. Lyons, Theo Bijma, Laura van Keep, Kirsten Wesenhagen, Aldo Jongejan, Henric Olsson, Niek de Vries, Taco W. Kuijpers, Peter Heeringa, Sander W. Tas

Summary: B lineage cells play a critical role in ANCA-associated vasculitis (AAV), and the transcription factor NF-kappa B may be a potential therapeutic target for AAV and other autoimmune diseases with prominent B cell involvement.

JOURNAL OF AUTOIMMUNITY (2024)

Article Immunology

K2P2.1 is a regulator of inflammatory cell responses in idiopathic inflammatory myopathies

Christopher Nelke, Thomas Muentefering, Derya Cengiz, Lukas Theissen, Vera Dobelmann, Christina B. Schroeter, Helena Block, Corinna Preu, Alexander P. E. Michels, Stefanie Lichtenberg, Marc Pawlitzki, Steffen Pfeuffer, Niklas Huntemann, Alexander Zarbock, Thorben Briese, Christoph Kittl, Carsten Dittmayer, Thomas Budde, Ingrid E. Lundberg, Werner Stenzel, Sven G. Meuth, Tobias Ruck

Summary: K2P2.1 plays a regulatory role in the autoimmune response of idiopathic inflammatory myopathies (IIMs), by regulating inflammatory cell response, adhesion, and transmigration in both endothelial and skeletal muscle cells. Inhibiting K2P2.1 enhances the inflammatory response, while activating K2P2.1 improves the disease course.

JOURNAL OF AUTOIMMUNITY (2024)

Article Immunology

2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis

Xuan Zhang, Jun Xia, Ying Jiang, David S. Pisetsky, Josef S. Smolen, Rong Mu, Shengming Dai, Michael E. Weinblatt, Tore K. Kvien, Juan Li, Thomas Doerner, Yu Zhang, Liwei Lu, Chengde Yang, Pingting Yang, Yuan Zhang, Chenchen Xu, Zhan Zhao, Peter E. Lipsky

Summary: The study suggests that TwHF may be as effective as MTX in treating active RA, and combination therapy may be more effective than monotherapy.

JOURNAL OF AUTOIMMUNITY (2024)

Article Immunology

Novel and unique rheumatoid factors cross-react with viral epitopes in COVID-19

Maya F. Amjadi, Maxwell H. Parker, Ryan R. Adyniec, Zihao Zheng, Alex M. Robbins, S. Janna Bashar, Michael F. Denny, Sara S. Mccoy, Irene M. Ong, Miriam A. Shelef

Summary: Rheumatoid factors (RFs) are polyreactive antibodies that can bind disease-specific epitopes. Recent studies have found that RFs in COVID-19 can bind novel IgG epitopes, which provides new insights into the mechanism of RFs.

JOURNAL OF AUTOIMMUNITY (2024)

Article Immunology

Risk factors for hypogammaglobulinemia and association with relapse and severe infections in ANCA-associated vasculitis: A cohort study

Johanne Liberatore, Yann Nguyen, Jerome Hadjadj, Pascal Cohen, Luc Mouthon, Xavier Puechal, Loic Guillevin, Benjamin Terrier

Summary: B-cell depletion induced by rituximab (RTX) in ANCA-associated vasculitis (AAV) can lead to decreased gammaglobulin levels, which is associated with an increased risk of relapse and severe infections. Older age, low gammaglobulin levels, and receiving pulses of methylprednisolone at induction therapy are risk factors for gammaglobulin decline.

JOURNAL OF AUTOIMMUNITY (2024)